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Abstract  26 
The behaviour of oligosaccharides from lactulose (OsLu) included with milk was 27 
examined during in vitro gastrointestinal digestion using the Infogest protocol as well as 28 
some small intestine rat extract. The digestion was compared with commercial 29 
prebiotics GOS and Duphalac®. Electrophoretic analysis demonstrated that the prebiotic 30 
carbohydrates did not modify the gastric digestion of dairy proteins. Similarly, no 31 
significant effect of gastrointestinal digestion was shown on the prebiotic studied. In 32 
contrast, under the intestinal conditions using a rat extract, the oligosaccharides 33 
presented in OsLu samples were less digested (< 15%) than in GOS (35%). Moreover, 34 
lactulose was more prone to digestion than their corresponding trisaccharides. These 35 
results demonstrate the limited digestion of OsLu and their availability to reach the 36 
large intestine as prebiotic.          37 
 38 
 39 
 40 
 41 
Keywords: lactulose oligosaccharides, prebiotics, digestion, milk, galacto-42 
oligosaccharides  43 
3 
 
1. Introduction 44 
Prebiotics can reach the distal portions of the colon to selectively stimulate the 45 
growth of bifidobacteria and lactobacilli, providing important benefits to health (Gibson 46 
et al., 2004). The most relevant compounds are oligosaccharides. These prebiotics may 47 
exert other bioactive properties such as improving mineral absorption and metabolic 48 
disorders and slow gastric emptying, among other effects (Moreno et al., 2014). 49 
Several commercial preparations of galactooligosaccharides (GOS) and 50 
fructooligosaccharides (FOS) are used as prebiotic ingredients in some foods such as 51 
infant formula and dairy products (Sabater et al., 2016). Lactulose (i.e. lactose isomer) 52 
is also a recognized prebiotic for the treatment of constipation and systemic portal 53 
encephalopathy (Corzo-Martínez et al., 2013). Given the huge interest in recent years 54 
towards the gastrointestinal function and new structures with improved properties, new 55 
routes to obtain a second-generation of prebiotic oligosaccharides are being explored 56 
(Moreno et al., 2017). This is the case of the oligosaccharides derived from lactulose 57 
(OsLu). These prebiotic mixtures, REWDLQHG E\ HQ]\PDWLF V\QWKHVLV XVLQJ ȕ-58 
galactosidases from microbial origin, might impart better prebiotic properties than 59 
commercial GOS (Moreno et al., 2014).  60 
One of the requirements for oligosaccharides to be considered as prebiotics is their 61 
resistance to digestion in the upper gastrointestinal tract. The susceptibility of prebiotic 62 
oligosaccharides to hydrolysis during their passage through the gastrointestinal tract is 63 
largely affected by the chemical structure and can impact their final state when they 64 
reach the colon to be fermented by the microbiota. Ohtsuka et al. (1990) found that the 65 
WULVDFFKDULGH ¶-galactosyl-lactose was hardly digested in vitro with a homogenate of 66 
intestinal mucosa of rats. According to Torres et al. (2010), more than 90% of GOS are 67 
stable to digestive enzymes and can reach the colon to exert their positive effect. 68 
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Carbohydrate analysis before and after exposure to certain protocols of in vitro 69 
digestion have shown that xylo-oligosaccharides, palatinose condensates, commercial 70 
GOS and lactulose were very resistant to hydrolysis, In contrast, lactosucrose, gentio-71 
oligosaccharides, soybean oligosaccharides, fructo-oligosaccharide and inulin were 72 
slightly hydrolysed under such conditions (Playne and Crittenden, 2009). 73 
To our knowledge, limited studies have been carried out on the digestibility of 74 
OsLu. Hernandez-Hernandez et al. (2012) pointed out in in vivo assays a higher 75 
resistance of OsLu compared to GOS during gastrointestinal digestion. This was 76 
DVFULEHG WR WKHSUHVHQFHRI IUXFWRVH LQȕĺ4) linkage with galactose at the reducing 77 
end of the OsLu molecules. However, there is a lack of studies on the susceptibility of 78 
OsLu to the gastrointestinal digestion when they are added in a food matrix and the 79 
impact of these compounds on the digestion of other food components. These 80 
considerations are important since standards would be more prone to changes as they 81 
are not protected in a food medium. Establishing the digestibility of prebiotic 82 
carbohydrates is of great practical application, since this influence the final dose of 83 
substrate that reaches the distal portions of gut to exert its prebiotic effect. Thus, the aim 84 
of this work has been to study the effect of the OsLu inclusion in milk on the digestion 85 
of proteins and the changes in the carbohydrate fraction using standardised in vitro 86 
digestive conditions with a more physiological relevant gastric digestion approach. A 87 
subsequent treatment with a rat small intestine extract has been included to study the 88 
effect of intestinal enzymes from mammals. The commercial prebiotics GOS and 89 
Duphalac® were also employed for comparison purposes. 90 
 91 
2. Materials and methods 92 
2.1. Chemicals and reagents 93 
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Galactose, D-glucose, fructose, lactose, lactulose, raffinose, stachyose, phenyl-ȕ-94 
glucoside and Intestinal acetone powders from rat (rat intestine extract) from Sigma-95 
Aldrich chemical Company (St Louis, MO).  96 
2.2.Obtainment of prebiotic ingredients 97 
OsLu were obtained at pilot scale by Innaves S.A. (Vigo, Spain) following the 98 
method described by Anadón et al. (2013). In brief, OsLu were synthesised using a 99 
commercial lactulose preparation (670 g/L; Duphalac®, Abbott Biologicals B.V., Olst, 100 
The Netherlands), diluted with water to 350 g/L and pH adjusted to 6.7 with KOH, and 101 
ȕ-galactosidase from Aspergillus oryzae (16 U/mL; Sigma), selected by its high yield 102 
for synthesis of OsLu (Cardelle-Cobas et. al., 2016). Enzymatic reactions were carried 103 
RXW DW  Û& LQ DQ RUELWDO VKDNHU DW  USP IRU  K $IWHUZDUGs, samples were 104 
immediately immersed in boiling water for 10 min to inactivate the enzyme. The 105 
mixture of oligosaccharides (20% [w/v]) was treated with fresh Saccharomyces 106 
cerevisiae (1.5% [w/v]; Levital, Paniberica de Levadura S.A., Valladolid, Spain) at 107 
30ºC and aeration at 20 L/min, to decrease the monosaccharides content (Sanz et al., 108 
2005). Finally, the samples were vacuum concentrated at 40 ºC in a rotary evaporator 109 
(Büchi Labortechnik AG, Flawil, Switzerland). GOS syrup was kindly provided by 110 
Friesland Campina Domo (Hanzeplein, The Netherlands). 111 
 112 
2.3.Milk samples  113 
Skim Milk Powder (low-heat organic, protein 42.34%, fat 0.89%, lactose 49.8% 114 
(w/w) (SMP) was kindly provided by Fonterra NZ. The SMP was reconstituted at 10% 115 
with distilled water and, subsequently, lactulose (Duphalac®), GOS or OsLu were added 116 
at 5% (w/w), taking into account previous recommendations for prebiotic doses (3.3 g 117 
of prebiotic carbohydrates/100 mL) (Walton et al., 2012; Whisner et al., 2013; Lopez-118 
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Sanz et al., 2015). The samples were labeled as SMP+Duphalac®, SMP+GOS and 119 
SMP+OsLu and were kept refrigerated until subsequent assays. 120 
 121 
2.4. In vitro gastrointestinal digestion 122 
The solutions (see Figure 1) used for the simulation of the oral and gastric phases 123 
were based on the standardized static digestion protocol Infogest (Minekus et al., 2014). 124 
5 mL of sample was placed into a 70 mL glass v-form vessel thermostated at 37 oC. To 125 
simulate the oral phase, 4 mL of Simulated Salivary Fluid (SSF, Table 1S, Verhoeckx et 126 
al., 2015), 25 µL 0.3 M CaCl2(H2O) and 0.975 mL Milli-Q water were added and mixed 127 
for approximately 2 min using a 3D action shaker (Mini-gyro rocker-SSM3-Stuart, 128 
Barloworld Scientific limited, UK) at 35 rpm. The simulation of the gastric phase was 129 
conducted using a semi-dynamic model described by Mulet-Cabero et al., (2017). The 130 
gastric fluids and enzyme solution were added gradually. Two solutions were added at a 131 
constant rate for 2 h: (1) 9 mL of a mixture consisted of 88.9% Simulated Gastric Fluid 132 
(SGF), 0.06% 0.3 M CaCl2(H2O), 4.4% Milli-Q water and 6.7% 2 M HCl was added 133 
using the dosing device of an autotitrator (836 Titrando-Metrohm, Switzerland) and (2) 134 
1 mL of pepsin (3,214 U/mg solid, using haemoglobin as substrate) solution (in water) 135 
was added to reach the protease activity of 2,000 U/mL in the final digestion mixture. 136 
This enzyme solution was added using a syringe pump (Harvard apparatus, PHD ultra, 137 
USA). The system was agitated using the 3D action shaker at 35 rpm during the 138 
digestion time. 139 
The pH was recorded throughout the procedure. Samples (0.5 mL) were taken after 140 
0, 1 and 2 h of digestion and the pepsin activity was stopped with 100 PL of 1 M 141 
NaHCO3 for a subsequent analysis of the protein fraction and the rest of the sample with 142 
150 PL of 5 M NaOH for the following intestinal digestion. This last sample was 143 
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labelled as GPhase sample. After gastric digestion two different procedures for small 144 
intestinal digestion were carried out:  145 
i) 2 mL of GPhase was freeze-dried and kept at -20°C until used for intestinal 146 
digestion assays with a crude enzyme of rat small intestine extract (RSIE). 5 mg 147 
of GPhase was mixed with 100 mg of RSIE and 1 mL distilled water. The 148 
mixture was incubated at 37° for 2 h, taking samples after 0, 0.5, 1 and 2 h. 149 
These samples were centrifuged at 10,000 rpm for 2 min and 100 µL of the 150 
supernatant was taken for carbohydrate analysis.  151 
ii) The rest of the liquid GPhase (~ 16.5 mL) was subjected to the small intestine 152 
conditions following the Infogest Protocol (Minekus et al., 2014). The digestion 153 
was carried out at 37°C for 2 h. Samples (5 mL) were taken at 0, 1 and 2 h of 154 
small intestinal digestion, which were respectively labelled as 0-IPhase, 1-155 
IPhase and 2-IPhase. They were freeze-dried until further analysis. 156 
 157 
2.5.Protein determination  158 
The changes in the protein fraction during gastric digestion of milk containing 159 
prebiotic ingredients (GPhase 0, 1 and 2 h) were followed by SDS-PAGE. 65 µL of 160 
sample was mixed with 2 ȝ/ RI ; 1X3$*( /6' VDPSOH EXIIHU ,QYLWURJHQ161 
Carlsbad, California, USA) and ȝ/RIGLWKLRWKUHLWROThe mixture was heated 162 
at 70 ºC for 10 min.  ȝ/ of mixture was loaded on a 12% polyacrylamide 163 
NuPAGE Novex Bis-Tris precast gel (Invitrogen,Carlsbad, California, USA) and 164 
RunBlue Precast SDS-PAGE gel cassette (Expedeon Ltd., Cambridgeshire, United 165 
Kingdom). SDS-3$*(ZDVSHUIRUPHGDFFRUGLQJWRWKHPDQXIDFWXUH¶VLQVWUXFWLRQV166 
Mark 12 Unstained Standard (Invitrogen) was used as a molecular weight marker 167 
(ranging from 2.5 to 200 kDa).  168 
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 169 
2.6.Carbohydrate analysis by GC-FID 170 
Trimethyl silylated oximes (TMSO) of carbohydrates (mono-, di- and 171 
trisaccharides) present in samples were determined by Gas Chromatography following 172 
the method described by Montilla et al. (2009). Samples corresponding to 0.5 mg of 173 
saccharides were added to 0.2 mL of Internal Standard (I.S.) solution which contained 174 
0.5 mg/mL of phenyl-ȕ-glucoside. Response factors respect to I.S. were calculated after 175 
the duplicate analysis of standard solutions (fructose, galactose, glucose, lactose, 176 
lactulose, sucrose, raffinose and stachyose), at different concentrations ranging from 177 
0.005 to 4 mg/mL.  178 
 179 
2.9. Statistical analysis 180 
All digestions were carried out in duplicate and analyses were also performed in 181 
duplicate (n=4). The comparison of means was carried out using one-way analysis of 182 
variance (Tukey HSD Multiple Range Test). Statistical analyses were performed using 183 
the SPSS statistical package (Inc., Chicago, Il). The differences were considered 184 
significant when P < 0.05. 185 
 186 
3. Results and discussion 187 
3.1.Effect on protein digestion  188 
Figure 1S (complementary material) shows the pH profile of the different samples 189 
of SMP with the addition of prebiotic ingredients (Table 2S, carbohydrate composition 190 
analysed by GC-FID) during their digestion in the semi-dynamic gastric model. The 191 
initial pH values were close to 7 in all cases and gradually decreased to 1.8 at the end of 192 
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the gastric digestion. In general, the profiles of the milk samples with prebiotic 193 
ingredients were similar to that of the SMP (no prebiotic ingredient added). The gradual 194 
lowering of pH enables the restructuring of the proteins due to acid induced coagulation 195 
to be simulated and is based on typical pH profiles measured in vivo (Malagelada et al. 196 
1979).  197 
The electrophoretic profile of proteins corresponding to samples 0, 1 and 2 h of 198 
gastric digestion are illustrated in Figures 2 and 3. These figures show bands of pepsin, 199 
caseins, BSA, ȕ-lactoglobulin ȕ-/JDQGĮ-lactalbumin (D-La). In the case of mixtures 200 
with OsLu and GOS at 0 h (Figure 2) more intense bands appeared in the area 201 
corresponding to D-La, probably due to the formation of complexes between the protein 202 
and carbohydrates, which disappeared during the digestion. In general, after 2 h of 203 
gastric digestion, the bands corresponding to undigested proteins from both SMP and 204 
SMP with added prebiotics were not detected with the exceptLRQ RI ȕ-Lg which has 205 
been shown to be more resistant to pepsin hydrolysis (Mandalari et al. 2009). Figure 3 206 
shows some diffuse, low molecular weight bands in samples corresponding to 1 and 2 h 207 
of digestion which could be related to small molecular weight peptides formed after 208 
milk protein digestion (lanes 5-12). The intensity of these bands was estimated by the 209 
Quantity One software. This showed an increase of intensity with digestion time 210 
obtaining values of 0.54 at 0.62 after 1 h and 0.64 at 0.75 after 2 h, with the lowest 211 
values corresponding to skim milk control.  212 
These results show that the SDS-PAGE profile of milk with prebiotic 213 
carbohydrates was similar to that of milk without addition of these ingredients, 214 
indicating that the presence of these prebiotics in milk at the concentration required to 215 
achieve a prebiotic effect, did not modify the gastric digestion of dairy proteins. 216 
 217 
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3.2.Effect on carbohydrate fraction  218 
The effect of gastrointestinal digestion on the three different prebiotics, Duphalac®, 219 
GOS and OsLu included in milk was investigated. For this purpose, the samples from 220 
the semi-dynamic gastric model were subjected to two different intestinal digestion 221 
protocols, as indicated above (Infogest protocol or RSIE). In the case of the Infogest 222 
method, Figure 2S (complementary material) illustrates, as an example, the 223 
chromatogram obtained by GC-FID of TMSO derivatives of carbohydrates present in 224 
the milk samples with OsLu after gastric digestion and the beginning of the intestinal 225 
phase (G+I 0 h). The peaks corresponding to carbohydrates with degree of 226 
polymerisation (DP) from 1 to 4 were found; among them galactose, lactulose and di-, 227 
tri- and tetrasaccharides derived from OsLu ingredient, and galactose, glucose and 228 
lactose from milk. Galactose was present in SMP with OsLu in higher proportion than 229 
in SMP with GOS (Table 1) in which the most abundant monosaccharide was glucose, 230 
due to their presence in the original prebiotic mixtures. In this respect, the addition of 231 
OsLu to milk or other products could be more interesting since OsLu presents lower 232 
proportion of caloric carbohydrates with lower glycaemic index than GOS (López-Sanz 233 
et al. 2015). As observed in Table 1, SMP+Duphalac® had higher concentration of 234 
lactulose than SMP+OsLu because lactulose is used as substrate during its enzymatic 235 
hydrolysis and transgalactosylation. 236 
Limited modifications were observed in the carbohydrate fraction following 237 
digestion using the Infogest protocol. In spite of the fact that there was a slight decrease 238 
of OS and trisaccharides in SMP+GOS after 2 h of digestion, these differences were not 239 
statistically significant. None of the carbohydrates derived from the prebiotic 240 
ingredients provided any significant change, indicating their stability during this 241 
enzymatic digestion by pancreatic fluids and bile salts. Moreover, it seems to be clear 242 
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that the presence of other milk components did not impact the passage of GOS, 243 
Duphalac® and OsLu throughout the gastrointestinal digestion evaluated by the Infogest 244 
protocol.  245 
In order to gain more insight in this subject and given that the Infogest protocol is 246 
mainly focus on the digestion of proteins, this study was completed with the evaluation 247 
of carbohydrate fraction of SMP with the three prebiotic ingredients after a subsequent 248 
digestion by means of an intestinal extract of from rats, labelled as RSIE, as indicated in 249 
Materials and Methods section. Figure 4 A, B, C, D illustrates the evolution of each 250 
carbohydrate fraction in the SMP added with Duphalac®, GOS and OsLu after their 251 
gastric and intestinal (Infogest) and with RSIE (0.5, 1 and 2 h) of digestion. Data are 252 
expressed as % of hydrolysis, for lactose, lactulose and oligosaccharides, and increase 253 
of monosaccharides, taking into account the control samples immediately taken after the 254 
addition of RSIE. TKH K\GURO\VLV RI FRPSRXQGV ZLWK '3   and mainly lactose 255 
increased with time of reaction, probably due to the presence of lactase ȕ-256 
galactosidase) in the RSIE, in good agreement with the increase of the monosaccharide 257 
proportion.  258 
In general, lactose was more hydrolysed than lactulose due to the presence of 259 
fructose instead of glucose in the ȕOLQNDJHof the latter (Olano and Corzo, 2009), being 260 
SMP+Duphalac® the sample with the highest degree of hydrolysis of lactose. In general, 261 
no significant differences (p >  0.05) were found for SMP samples with OsLu and GOS. 262 
Lactulose was significantly less susceptible to hydrolysis in SMP+Duphalac® than in 263 
SMP+OsLu. Furthermore, lactulose present in OsLu and Duphalac® was more prone to 264 
degradation than OS, probably ascribed to its lower Mw, although the difference was 265 
only significant after 1 h of digestion. Finally, OS were significantly more hydrolysed in 266 
SMP+GOS than in SMP+OsLu reaching values of 35% and 15%, respectively after 2 h; 267 
12 
 
this was probably due to the more VWDEOH ȕ-6) linkages in the OsLu mixture as 268 
FRPSDUHGWRȕ-4) in GOS and the presence of fructose at the terminal end of molecule 269 
(Hernandez-Hernandez et al. 2012). 7KHVH UHVXOWV LQGLFDWH WKDW 26 '3 SUHVHQW LQ270 
OsLu were scarcely affected by the gastrointestinal digestion under the conditions used 271 
in the present work, being digested in a very low proportion in the small intestine which 272 
would favour the presence of a OS in the distal portions of colon to be fermented by 273 
beneficial bacteria. 274 
To the best of our knowledge this is the first in vitro study on the digestion of 275 
prebiotics derived from lactose and lactulose as ingredients in a real food. The results 276 
obtained underline those of Hernandez-Hernandez et al. (2012) who pointed out, in in 277 
vivo assays with rats, that mixtures of OsLu were less digested than GOS. Particularly, 278 
the trisaccharide fraction of the former was 13% digested in the ileum, whereas in the 279 
latter case digestion was close to 53%. In both cases, the studied samples were the 280 
corresponding enzymatic mixtures obtained by transglycosylation and the presence of 281 
other food components was not considered. The small differences found in the total 282 
hydrolysis values with respect of our results could be ascribed to the differences in the 283 
experimental conditions.  284 
 285 
Conclusions 286 
According to the results obtained is possible to conclude that the presence of 287 
prebiotic carbohydrates in milk, at prebiotic doses, did not affect the gastric digestion of 288 
milk proteins, following the Infogest protocol. Similarly, under the same gastrointestinal 289 
digestion method, hardly any change was detected in the carbohydrate fraction of milk 290 
with GOS, Duphalac® and OsLu after 2 h of digestion. This might indicate the 291 
resistance of the three prebiotic mixtures, including OsLu, to gastric and pancreatic 292 
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fluids and bile salts. However, when the digested samples of milk with prebiotics were 293 
subjected to intestinal digestion by a small gut intestinal extract of rat a dissimilar 294 
behaviour in the three cases was observed, OsLu samples being the most resistant to the 295 
action of enzymes present in the rat intestine extract, mainly in the case of OS fraction. 296 
These results highlight the possibility of OsLu to reach the large intestine, target organ, 297 
to exert their potential prebiotic effects.  298 
   299 
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Figure caption 403 
Figure 1. Scheme of the experimental procedure. 404 
Figure 2. (OHFWURSKRUHWLFSURILOHVRIPLONSURWHLQIUDFWLRQVFDVHLQVȕ-/JĮ-La, BSA) 405 
before and after 2 h of digestion (Bis-Tris-Gel, Novex, NuPage). M: Marker, 1: SMP 0 406 
h, 2: SMP 2 h, 3: SMP+OsLu 0 h, 4: SMP+OsLu 2 h, 5: SMP+ Duphalac 0 h, 6: 407 
SMP+Duphalac® 2 h, 7: SMP+GOS 0 h, 8: SMP + GOS 2 h, 9: blank  408 
Figure 3. Electrophoretic profiles RIPLONSURWHLQIUDFWLRQVFDVHLQVȕ-/JĮ-La, BSA) 409 
during 0, 1 and 2 h of digestion (RunBlue Precast gels). M: Marker; 1, 5 and 9 SMP; 2, 410 
6 and 10 SMP+OsLu; 3, 7 and 11 SMP+GOS; 4, 8 and 12 SMP+Duphalac. *Optical 411 
density was measured in the maximum of the peak with the Software Quantity One.  412 
Figure 4. Evolution of carbohydrates over time during the gastric and intestinal 413 
digestion with RSIE. Figure shows the results for each fraction analyzed A) 414 
Monosaccharides, B) Lactose, C) Lactulose and D) Oligosaccharides after 0.5, 1.0 and 415 
2.0 h of digestion. Grey bar represents SMP samples; Striped bar, SMP+Duphalac; 416 
Black bar, SMP+GOS and White bar, SMP+OsLu. The results are shown as percentage 417 
of increase (A) or hydrolysis (B, C, D) relatively to their respective controls. Results are 418 
presented as mean ± SD (n=4). Bar with different lower-case letters (a±d) represent 419 
statistical significant differences between each carbohydrate fraction at the same 420 
digestion time for their mean values at the 95.0 % confidence. 421 
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 422 
423 Table 1 ± Carbohydrate evolution of milk samples during Intestinal digestion (G+I Phase), according to Infogest Protocol. 
 
  Carbohydrate content (%)  
  
Galactose 
 
Glucose 
 
Lactulose 
 
Lactose 
 
Other 
Disaccharides 
 
Trisaccharides 
 
Tetrasaccharides 
 
Oligosaccharides* 
 
SMP 0h 0.3 ± 0.1  0.4 ± 0.2 N.D. 99.4 ± 0.2 N.D. N.D. N.D. N.D. 
 
1h 0.3 ± 0.1 0.5 ± 0.1 N.D. 99.2 ± 0.1 N.D. N.D. N.D. N.D. 
 
2h 0.3 ± 0.0 0.4 ± 0.2 N.D. 99.4 ± 0.2 N.D. N.D. N.D. N.D. 
 
         SMP + GOS 0h 0.5 ± 0.1 7.6 ± 1.0 N.D. 65.6 ± 3.7 11.0 ± 0.8 12.9 ± 1.8 2.4 ± 0.6 26.4 ± 3.1 
 
1h 0.5 ± 0.0 7.7 ± 1.5 N.D. 66.3 ± 3.3 12.0 ± 2.2 12.3 ± 1.4 3.3 ± 0.7 27.6 ± 4.2 
 
2h 0.5 ± 0.0 6.9 ± 0.2 N.D. 68.4 ± 1.4 10.8 ± 1.3 10.9 ± 0.7 2.4 ± 1.7 24.1 ± 1.5 
 
         SMP + Duphalac® 0h 3.6 ± 0.4 0.4 ± 0.4 22.0 ± 5,1 73.6 ± 4.9 N.D. N.D. N.D. N.D. 
 
1h 3.4 ± 0.8 0.2 ± 0.2 20.6 ± 1,1 76.5 ± 1.1 N.D. N.D. N.D. N.D. 
 
2h 3.1 ± 0.2 0.4 ± 0.2 21.6 ± 1,9 75.6 ± 1.7 N.D. N.D. N.D. N.D. 
 
         SMP + OsLu 0h 5.0 ± 0.3 0.3 ± 0.1 6.3 ± 2.1 68.4 ± 1.7 9.8 ± 0.3 9.3 ± 0.2 0.9 ± 0.2 20.1 ± 0.6 
 
1h 5.0 ± 0.1 0.4 ± 0.2 7.1 ± 1.4 67.4 ± 1.3 9.8 ± 0.4 9.5 ± 0.4 0.8 ± 0.3 20.1 ± 0.3 
 
2h 5.3 ± 0.3 0.3 ± 0.0 6.0 ± 0.4 69.0 ± 1.1 10.2 ± 0.5 8.6 ± 1.0 0.8 ± 0.6 19.6 ± 1.6 
The data are expressed as the mean ± SD (p>0.05). No statistical difference was determinates between 0, 1 and 2 h samples in all compounds using a one-way analysis of 
variance (ANOVA) (n=4). N.D. No detected. 
*Oligosaccharides: Values represent the sum of di-, tri- and tetrasaccharides. 
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- Prebiotic carbohydrates added to milk do not modify the gastric digestion of 
proteins 
- Carbohydrates keep stable at enzymatic digestion by pancreatic fluid and bile 
salts 
- Lactulose was more prone to digestion than their corresponding trisaccharides  
- Oligosaccharides derived from lactulose were less digested than those from 
lactose 
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Table 1S. Composition of simulated salivary fluid (SSF) 
 
Constituent SSF (pH 7) /mmol/L) 
 
K+ 18.8 
Na+ 13.6 
Cl- 19.5 
H2PO4- 3.7 
HCO3-, CO32- 13.7 
Mg2+ 0.15 
NH4+ 0.12 
Ca2+ 1.2 
Į-amilase at 150 units per mL of SSF (Verhoeckx et al., 2015) 
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Table 2S. Carbohydrate composition (% of total carbohydrates) of OsLu, Vivinal®GOS and Duphalac®. 
 
Samples Glucose Fructose Galactose Other 
Disaccharides 
Lactose Lactulose Trisaccharides Tetrasaccharides Pentasaccharides Hexasaccharides 
OsLu - - 14.1 
(1.0) 
21.1 
(1.1) 
N.D. 26.1 
(1.2) 
25.6 
(0.7) 
9.7 
(0.7) 
2.6 
(0.6) 
0.2 
(0.1) 
Vivinal®GOS 20.7 
(2.1) 
- 1.4 
(0.1) 
20.5 
(0.6) 
18.0 
(0.2) 
- 21.0 
(0.7) 
13.1 
(0.8) 
4.8 
(0.6) 
0.7 
(0.4) 
Duphalac® 0.3 
(0.0) 
- 7.9 
(0.7) 
- 3.2 
(0.2) 
88.7 
(0.6) 
- - - - 
Data are expressed as the mean (SD) (p>0.05).  
N.D. No detected. 
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Figure 1S. pH profile of milk samples with the prebiotic ingredients during gastric 
digestion. 
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Figure 2S. GC-FID profile of TMSO derivatives of carbohydrates present in milk 
samples with OsLu after 1 h of gastric digestion. Peak 1 Galactose; 2 Glucose; 3 
Galactose + Glucose; I.S. Internal Standard; 4 Lactose; 5 Other disaccharides. * Matrix 
effect, DP: Degree of Polymerisation. 
 
 
 
 
 
 
 
 
 
 
 
